Maximizing HIV Organ Policy Equity for transplant candidates with HIV [0.03%]
最大化器官分配政策的公平性以造福HIV阳性供者和移植接受者
Brian J Boyarsky,Christine M Durand,Peter G Stock
Brian J Boyarsky
The adverse effects of high-dose corticosteroid on infectious and non-infectious sequelae in renal transplant recipients with coronavirus disease-19 in India [0.03%]
印度肾移植受者新型冠状病毒疾病应用大剂量皮质类固醇的不良作用：对感染性和非感染性后遗症的影响
Vamsidhar Veeranki,Narayan Prasad,Jeyakumar Meyyappan et al.
Vamsidhar Veeranki et al.
Introduction: The corticosteroid dosing modulation in renal transplant recipients (RTRs) with coronavirus disease-19 (COVID-19) is not well defined. We aimed to analyze the outcomes and infectious and non-infectious seque...
Risk factor analysis for cytomegalovirus reactivation under prophylaxis with letermovir after allogeneic hematopoietic stem cell transplantation [0.03%]
预防性使用莱特莫韦后allo-HSCT受者巨细胞病毒再活化的危险因素分析
Kota Mizuno,Masatoshi Sakurai,Jun Kato et al.
Kota Mizuno et al.
Background: Letermovir has been approved as a novel cytomegalovirus (CMV) prophylactic agent after allogeneic hematopoietic stem cell transplantation (HSCT). However, there are still insufficient data to properly evaluate...
Healthcare disparity and its associations with cytomegalovirus disease in pediatric liver transplant recipients in South Africa [0.03%]
南非儿童肝移植受者的医疗差异及其与巨细胞病毒感染的关系
Priya Walabh,David P Moore,Graham Paget et al.
Priya Walabh et al.
Background: Cytomegalovirus (CMV) infection and disease are preventable complications following pediatric liver transplantation (PLT), despite the use of prophylaxis to minimize the risk of CMV disease. We evaluated the i...
Moving xenotransplantation from bench to bedside: Managing infectious risk [0.03%]
从实验室到临床的异体移植：控制感染风险
Anoma Nellore,Jeremey Walker,Mauricio J Kahn et al.
Anoma Nellore et al.
Xenotransplantation of organs from swine in immunosuppressed human recipients poses many of the same challenges of allotransplantation relative to the risk for infection, malignancy, or graft rejection in proportion to the degree of immunos...
Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch [0.03%]
贝特洛维玛和索托罗维玛治疗奥密克戎时期轻中度新冠肺炎器官移植受者的效果
Zachary A Yetmar,Elena Beam,John C O&#x;Horo et al.
Zachary A Yetmar et al.
Background: Solid organ transplant recipients (SOTRs) are at high-risk for severe infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Anti-spike monoclonal antibodies are currently utilized under ...
Drug-level change and optimal dose adjustment of tacrolimus with the use of rifabutin for treating mycobacterial disease in solid organ transplant recipients [0.03%]
调整环孢素用药剂量以治疗器官移植受者的分枝杆菌感染
Ock-Hwa Kim,Tae Sun Shim,Kyung-Wook Jo
Ock-Hwa Kim
Background: Little is known about the change in drug level and the need for dose adjustment of calcineurin inhibitor when it is used with rifabutin in solid organ transplant (SOT) recipients. We aimed to analyze whether t...
Impact of narrowing perioperative antibiotic prophylaxis for left ventricular assist device implantation [0.03%]
左心室辅助装置植入手术抗菌药物预防用药时间窗窄化的临床影响分析
Lauren Allen,Rachel Bartash,Grace Y Minamoto et al.
Lauren Allen et al.
Background: Although infections are a significant potential complication among patients undergoing left ventricular assist device (LVAD) implantation, standardized surgical infection prophylaxis (SIP) regimens are not wel...
Elena Graziano,Maddalena Peghin,Paolo Antonio Grossi
Elena Graziano
Background: Solid organ transplant (SOT) recipients can benefit from traditional antimicrobial stewardship (AMS) activities directed to improve judicious perioperative prescribing and management, but evidence is lacking. ...
Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomes [0.03%]
肝移植受者高细胞巨病毒血症的相关危险因素及临床转归分析
Hanna L Kleiboeker,Margaret R Jorgenson,Glen E Leverson et al.
Hanna L Kleiboeker et al.
Purpose: To evaluate epidemiology, risk-factors, and outcomes of high-level (HL) cytomegalovirus (CMV) viremia in liver transplant recipients. Methods: ...